Waukesha, Wis.-based GE Healthcare announces that the U.S. FDA has granted FDA 510(k) clearance to its Signa 7.0T MRI scanner. With a magnet approximately five times stronger than most clinical systems, Signa 7.0T can image anatomy, function, metabolism, and microvasculature in the brain and joints with high resolution and detail. This new system can be used for both research and clinical purposes to support a broad range of investigations across neurologic and musculoskeletal diseases.
“We were immediately impressed with the quality and stability of the Signa 7.0T system,” says Michela Tosetti, PhD, laboratory director, IRCCS Stella Maris and Imago7 Research Foundations and professor, University of Pisa, who scanned on Signa7.0T at GE Healthcare MR headquarters earlier this year. “We are keen to upgrade our system to this new configuration continuing our relationship with GE to realize the promise of this technology to meet our imaging goals.”
With a 7.0 tesla magnet at its core, Signa 7.0T combines a broad range of advanced technology and imaging methods into a new imaging tool. Specifically, the Signa 7.0T features UltraG gradient technology, GE’s whole-body gradient coil, to meet the demands of ultra-high field imaging speed and resolution, advanced diffusion, and functional brain imaging.
This system also features GE’s latest SignaWorks software platform with applications such as deep learning-based tools like AIR x brain for automated slice positioning and Silent MR imaging, enabling seamless protocol translation between GE MR systems. In addition, Signa 7.0T is equipped with Precision RF transmit and receive architecture to enable improved image quality and enable development in parallel transmit. This system also provides a unique platform for advanced knee and cartilage imaging, allowing for ultra-high-resolution anatomical visualization as well as research capabilities to measure quantitative changes in anatomy due to disease.
“We are thrilled to add Signa 7.0T to our portfolio,” says Jie Xue, president and CEO of GE Healthcare MR. “This new scanner is a critical tool in research for neurological disorders like Alzheimer’s disease and mild traumatic brain injury. Now, clinicians will have access to the power of ultra-high field imaging combined with the ultra-high-performance gradients to translate research advances into new clinical diagnostic tools and potential treatment options.”